Trial Profile

Second phase III study of BUPI for pain management in oral mucositis in cancer patients

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 12 Aug 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bupivacaine (Primary)
Indications Pain
Focus Therapeutic Use
Sponsors Moberg Pharma

Most Recent Events

08 Aug 2017 According to a Moberg Pharma media release, during the second quarter the company provided input on this study application for BUPI to their partner Cadila Pharmaceuticals.Submission preparations by Cadila are in the final stages.
28 Mar 2016 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com